Symmetry Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-21,038
| Closed | -$874K | – | 147 |
|
|
2024
Q2 | $874K | Sell |
21,038
-1,107
| -5% | -$46K | 0.05% | 187 |
|
|
2024
Q1 | $1.2M | Hold |
22,145
| – | – | 0.09% | 146 |
|
|
2023
Q4 | $1.13M | Buy |
22,145
+3,117
| +16% | +$160K | 0.06% | 151 |
|
|
2023
Q3 | $1.1M | Sell |
19,028
-4,127
| -18% | -$239K | 0.06% | 165 |
|
|
2023
Q2 | $1.48M | Hold |
23,155
| – | – | 0.08% | 132 |
|
|
2023
Q1 | $1.61M | Buy |
23,155
+105
| +0.5% | +$7.28K | 0.09% | 121 |
|
|
2022
Q4 | $1.66M | Sell |
23,050
-8,397
| -27% | -$604K | 0.1% | 116 |
|
|
2022
Q3 | $2.24M | Sell |
31,447
-22,775
| -42% | -$1.62M | 0.15% | 78 |
|
|
2022
Q2 | $4.18M | Buy |
54,222
+35,303
| +187% | +$2.72M | 0.28% | 52 |
|
|
2022
Q1 | $1.38M | Buy |
18,919
+3,202
| +20% | +$234K | 0.09% | 142 |
|
|
2021
Q4 | $980K | Sell |
15,717
-1,494
| -9% | -$93.2K | 0.06% | 216 |
|
|
2021
Q3 | $1.02M | Hold |
17,211
| – | – | 0.07% | 214 |
|
|
2021
Q2 | $1.15M | Sell |
17,211
-1,371
| -7% | -$91.6K | 0.08% | 197 |
|
|
2021
Q1 | $1.17M | Buy |
18,582
+462
| +3% | +$29.2K | 0.08% | 171 |
|
|
2020
Q4 | $1.12M | Sell |
18,120
-208
| -1% | -$12.9K | 0.09% | 161 |
|
|
2020
Q3 | $1.11M | Sell |
18,328
-1,361
| -7% | -$82.1K | 0.09% | 146 |
|
|
2020
Q2 | $1.16M | Buy |
19,689
+752
| +4% | +$44.2K | 0.14% | 69 |
|
|
2020
Q1 | $1.06M | Buy |
+18,937
| New | +$1.06M | 0.23% | 48 |
|